These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
107 related articles for article (PubMed ID: 10615432)
1. Regulation of proteolytic enzymes and inhibitors in two smooth muscle cell phenotypes. Lau HK Cardiovasc Res; 1999 Sep; 43(4):1049-59. PubMed ID: 10615432 [TBL] [Abstract][Full Text] [Related]
2. T-cell lymphokines, interleukin-4 and gamma interferon, modulate the induction of vascular smooth muscle cell tissue plasminogen activator and migration by serum and platelet-derived growth factor. Wang W; Chen HJ; Giedd KN; Schwartz A; Cannon PJ; Rabbani LE Circ Res; 1995 Dec; 77(6):1095-106. PubMed ID: 7586221 [TBL] [Abstract][Full Text] [Related]
3. Regulation of baboon arterial smooth muscle cell plasminogen activators by heparin and growth factors. Kenagy RD; Clowes AW Thromb Res; 1995 Jan; 77(1):55-61. PubMed ID: 7701477 [TBL] [Abstract][Full Text] [Related]
4. The catalytic domain of endogenous urokinase-type plasminogen activator is required for the mitogenic activity of platelet-derived and basic fibroblast growth factors in human vascular smooth muscle cells. Padró T; Mesters RM; Dankbar B; Hintelmann H; Bieker R; Kiehl M; Berdel WE; Kienast J J Cell Sci; 2002 May; 115(Pt 9):1961-71. PubMed ID: 11956327 [TBL] [Abstract][Full Text] [Related]
5. T cell lymphokines modulate bFGF-induced smooth muscle cell fibrinolysis and migration. Wang W; Chen HJ; Schwartz A; Cannon PJ; Rabbani LE Am J Physiol; 1997 Feb; 272(2 Pt 1):C392-8. PubMed ID: 9124280 [TBL] [Abstract][Full Text] [Related]
6. [Effect of growth factors (BFGF and PDGF) on urokinase secretion by smooth muscle cells]. Mukhina SA; Stepanova VV; Matveev MIu; Domogatskiĭ SP; Tkachuk VA Vopr Med Khim; 1998; 44(1):84-90. PubMed ID: 9575617 [TBL] [Abstract][Full Text] [Related]
7. Urokinase and tissue-type plasminogen activator are required for the mitogenic and chemotactic effects of bovine fibroblast growth factor and platelet-derived growth factor-BB for vascular smooth muscle cells. Herbert JM; Lamarche I; Carmeliet P J Biol Chem; 1997 Sep; 272(38):23585-91. PubMed ID: 9295297 [TBL] [Abstract][Full Text] [Related]
8. Regulation of plasminogen activator inhibitor-1 secretion by growth factors in smooth muscle cells. Lau HK; Ho J Blood Coagul Fibrinolysis; 2002 Sep; 13(6):541-9. PubMed ID: 12192306 [TBL] [Abstract][Full Text] [Related]
9. Regulation of plasminogen activator inhibitor-1 secretion by urokinase and tissue plasminogen activator in rat epithelioid-type smooth muscle cells. Lau HK; Ho J Br J Haematol; 2002 Apr; 117(1):151-8. PubMed ID: 11918547 [TBL] [Abstract][Full Text] [Related]
10. Combined effect of retinoic acid and basic FGF on PAI-1 gene expression in vascular smooth muscle cells. Watanabe A; Kurabayashi M; Arai M; Sekiguchi K; Nagai R Cardiovasc Res; 2001 Jul; 51(1):151-9. PubMed ID: 11399257 [TBL] [Abstract][Full Text] [Related]
11. Pathogenetic implications of hyaluronan-induced modification of vascular smooth muscle cell fibrinolysis in diabetes. Marutsuka K; Woodcock-Mitchell J; Sakamoto T; Sobel BE; Fujii S Coron Artery Dis; 1998; 9(4):177-84. PubMed ID: 9649923 [TBL] [Abstract][Full Text] [Related]
12. The effect of endothelial cell overexpression of plasminogen activator inhibitor-1 on smooth muscle cell migration. Proia RR; Nelson PR; Mulligan-Kehoe MJ; Wagner RJ; Kehas AJ; Powell RJ J Vasc Surg; 2002 Jul; 36(1):164-71. PubMed ID: 12096275 [TBL] [Abstract][Full Text] [Related]
13. Activity and expression of urokinase-type plasminogen activator and matrix metalloproteinases in human colorectal cancer. Kim TD; Song KS; Li G; Choi H; Park HD; Lim K; Hwang BD; Yoon WH BMC Cancer; 2006 Aug; 6():211. PubMed ID: 16916471 [TBL] [Abstract][Full Text] [Related]
14. Effects of S-dC28 on vascular smooth muscle cell adhesion and plasminogen activator production. Wang W; Chen HJ; Warshofsky M; Schwartz A; Stein CA; Rabbani LE Antisense Nucleic Acid Drug Dev; 1997 Apr; 7(2):101-7. PubMed ID: 9149845 [TBL] [Abstract][Full Text] [Related]
15. Prostaglandin E2 regulates production of plasminogen activator isoenzymes, urokinase receptor, and plasminogen activator inhibitor-1 in primary cultures of rat calvarial osteoblasts. Allan EH; Martin TJ J Cell Physiol; 1995 Dec; 165(3):521-9. PubMed ID: 7593231 [TBL] [Abstract][Full Text] [Related]
16. Effects and mechanism of tissue-type plasminogen activator and plasminogen activator inhibitor on vascular smooth muscle cell proliferation. Xiaoli M; Wenying H; Mingpeng S Int J Cardiol; 1998 Oct; 66 Suppl 1():S57-64; discussion S65. PubMed ID: 9951803 [TBL] [Abstract][Full Text] [Related]
17. Plasminogen activator and plasminogen activator inhibitor expression by normal and aneurysmal human aortic smooth muscle cells in culture. Louwrens HD; Kwaan HC; Pearce WH; Yao JS; Verrusio E Eur J Vasc Endovasc Surg; 1995 Oct; 10(3):289-93. PubMed ID: 7552526 [TBL] [Abstract][Full Text] [Related]
18. Heparin and dibutyryl cAMP modulate gene expression in stimulated human saphenous vein smooth muscle cells. Yamaguchi M; Diamond S; Watanabe H; Gallati H; Baur W; Sharefkin JB In Vitro Cell Dev Biol Anim; 1993 Nov; 29A(11):867-72. PubMed ID: 8167903 [TBL] [Abstract][Full Text] [Related]
19. Losartan inhibits the angiotensin II-induced modifications on fibrinolysis and matrix deposition by primary human vascular smooth muscle cells. Papakonstantinou E; Roth M; Kokkas B; Papadopoulos C; Karakiulakis G J Cardiovasc Pharmacol; 2001 Nov; 38(5):715-28. PubMed ID: 11602818 [TBL] [Abstract][Full Text] [Related]
20. Smooth muscle cells express urokinase during mitogenesis and tissue-type plasminogen activator during migration in injured rat carotid artery. Clowes AW; Clowes MM; Au YP; Reidy MA; Belin D Circ Res; 1990 Jul; 67(1):61-7. PubMed ID: 2114227 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]